Skip to content
2000
Volume 4, Issue 1
  • ISSN: 2210-299X
  • E-ISSN: 2210-3007
file format text download EPUB
file format pdf download PDF
side by side viewer icon HTML

Abstract

Introduction:

Acyclovir is an antiviral drug used to treat herpes simplex keratitis, herpes simplex blepharitis, herpes simplex labialis, and other viral diseases. In the current work, the medication acyclovir, which is classified as BCS class III, was effectively incorporated using the solvent evaporation approach into polycaprolactone mucoadhesive microspheres. Additionally, polycaprolactone was used for the formulation of mucoadhesive microspheres for acyclovir.

Methods:

Polycaprolactone microspheres loaded with acyclovir were prepared by the w/o/w double emulsion solvent evaporation technique. Drug encapsulation in microspheres was verified using DSC and FTIR analyses. release studies showed that acyclovir was released continuously and in a sustained manner for up to 24 hours. The resulting microspheres had a consistent shape and were nearly spherical.

Results:

All of the microsphere formulations’ release patterns fit the Higuchi model, which indicates that the drug is released from granular and homogeneous matrix systems. After 30 days, it was observed that the microsphere formulations were fairly stable at 4 ± 2°C and 25 ± 2°C/60 ± 5% RH.

Discussion:

This work effectively illustrates the capability of poly(ε-caprolactone) (PCL)-based mucoadhesive microspheres for the prolonged release of acyclovir. The microspheres demonstrated excellent mucoadhesive properties, favorable particle size distribution, and good drug entrapment efficiency when prepared using a double emulsion solvent evaporation process. In contrast to the rapid release profile of conventionally sold tablets, the optimized formulation (F3) produced extended drug release over a 24-hour period, which is a considerable improvement.

Conclusion:

The drug release kinetics followed the Higuchi model, and a diffusion-erosion-based release pattern was confirmed by Korsmeyer-Peppas analysis, showing a non-Fickian diffusion mechanism. Overall, this formulation approach could provide a useful foundation for enhancing the functionality of other drugs with similar biopharmaceutical limitations.

© 2026 The Author(s). Published by Bentham Science Publishers.
This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cis/10.2174/012210299X386236251206100034
2025-12-22
2026-02-25

  • From This Site

    /content/journals/cis/10.2174/012210299X386236251206100034
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cis/4/1/CIS-4-E2210299X386236.html?itemId=/content/journals/cis/10.2174/012210299X386236251206100034&mimeType=html&fmt=ahah

References

  1. BhatiaM. DeviS. Co-crystallization: A green approach for the solubility enhancement of poorly soluble drugs.CrystEngComm202426329331110.1039/D3CE01047C
     [Google Scholar]
  2. WaqarM.A. MubarakN. KhanA.M. KhanR. ShaheenF. ShabbirA. Advanced polymers and recent advancements on gastroretentive drug delivery system; A comprehensive review.J. Drug Target.202432665567110.1080/1061186X.2024.234736638652465
     [Google Scholar]
  3. Vinod Kumar Sushma Somkuwar SinghaiA.K. KumarV. SomkuwarS. SinghaiA.K. A recent update on gastro retentive drug delivery systems.GSC Biol Pharm Sci202427112514410.30574/gscbps.2024.27.1.0119
     [Google Scholar]
  4. OmidianH. Gastroretentive drug delivery systems: A holy grail in oral delivery.Drug Discov. Today202530410434010.1016/j.drudis.2025.10434040122450
     [Google Scholar]
  5. DubeyA OvaisM BisenAC RajendiranA Advancements and challenges in gastroretentive drug delivery systems: A comprehensive review of research innovation, technologies, and clinical applications.Recent Adv. Drug Deliv. Formul.2025202510.2174/012667387834243025041411453140296614
     [Google Scholar]
  6. MaliR. PatilJ. Nanomaterials: An improvised drug delivery system through the gastroretentive drug delivery system.Materials Proceedings.20231416310.3390/IOCN2023‑14514
     [Google Scholar]
  7. Elsherbeeny El-GogaryR. NasrM. SammourO. Current progress of oral site-specific dosage forms: Emphasis on gastroretentive drug delivery systems.Arch Pharm Sci Ain Shams Univ20226222123810.21608/aps.2022.168128.1101
     [Google Scholar]
  8. DaveB.S. AminA.F. PatelM.M. Gastroretentive drug delivery system of ranitidine hydrochloride: Formulation and in vitro evaluation.AAPS PharmSciTech200452778210.1208/pt05023415760092
     [Google Scholar]
  9. DasS. KaurS. RaiV.K. Gastro-retentive drug delivery systems: A recent update on clinical pertinence and drug delivery.Drug Deliv. Transl. Res.20211151849187710.1007/s13346‑020‑00875‑533403646
     [Google Scholar]
  10. DeviS SharmaK. Review: Mucoadhesive microspheres a promising tool in drug delivery system.Int. J. Pharm. Res. Technol.2022122465310.31838/ijprt/12.02.07
     [Google Scholar]
  11. DeSunita SharmaK. Preparation and evaluation of ibuprofen loaded sodium alginate/sodium CMC mucoadhesive drug delivery system for sustained release.Acta Pharm. Sci.202260321710.23893/1307‑2080.APS.6015
     [Google Scholar]
  12. DeviS BhatiaM. Polymers for mucoadhesive drug delivery systems.Acta Pharm. Sci.202159234310.23893/1307‑2080.APS.05919
     [Google Scholar]
  13. SharmaY. MaharR. ChakrabortyA. NainwalN. Optimizing the formulation variables for encapsulation of linezolid into polycaprolactone inhalable microspheres using double emulsion solvent evaporation.Tuberculosis202314310241710.1016/j.tube.2023.10241737827017
     [Google Scholar]
  14. AmraneS. ChaalalM. BouricheS. YdjeddS. RezguiF. OuchemoukhS. Effect of microencapsulation conditions on phenolic compounds and antioxidant activity of propolis using double emulsion solvent evaporation approach.Acta Aliment.202352460161110.1556/066.2023.00170
     [Google Scholar]
  15. van der KooijR.S. SteendamR. FrijlinkH.W. HinrichsW.L.J. An overview of the production methods for core–shell microspheres for parenteral controlled drug delivery.Eur. J. Pharm. Biopharm.2022170244210.1016/j.ejpb.2021.11.00734861359
     [Google Scholar]
  16. TaoZ. YuanZ. ZhouD. QinL. XiaoL. ZhangS. LiuC. ZhaoJ. LiY. Fabrication of magnesium-doped porous polylactic acid microsphere for bone regeneration.Biomater. Transl.20234428029010.12336/biomatertransl.2023.04.00738282706
     [Google Scholar]
  17. BhatiaM. DeviS. Development, characterisation and evaluation of pvp k-30/peg solid dispersion containing ketoprofen.ACTA Pharmaceutica Sciencia20205818310.23893/1307‑2080.APS.05806
     [Google Scholar]
  18. BhatiaM. SrivastavM. DeviS. SharmaS.K. KakkarV. SainiK. Optimization and evaluation of ketoconazole loaded nanostructured lipid carriers employing microwave-assisted technique.Indian J. Pharm. Sci.202284110.36468/pharmaceutical‑sciences.907
     [Google Scholar]
  19. BhatiaM. KumarA. VermaV. DeviS. Development of ketoprofen-p-aminobenzoic acid co-crystal: Formulation, characterization, optimization, and evaluation.Med. Chem. Res.2021302090210210.1007/s00044‑021‑02794‑7
     [Google Scholar]
  20. DeviS. KumarS. VermaV. KaushikD. VermaR. BhatiaM. Enhancement of ketoprofen dissolution rate by the liquisolid technique: Optimization and in vitro and in vivo investigations.Drug Deliv. Transl. Res.202212112693270710.1007/s13346‑022‑01120‑x35178670
     [Google Scholar]
  21. DeviS. KumarA. KapoorA. VermaV. YadavS. BhatiaM. Ketoprofen–FA co-crystal: In vitro and in vivo investigation for the solubility enhancement of drug by design of expert.AAPS PharmSciTech202223410110.1208/s12249‑022‑02253‑535348937
     [Google Scholar]
  22. DeviS. BahmaniK. Rinkle Chitosan co-crystal for enhancing the solubility and dissolution rate of diclofenac sodium.Int. J. Pharm. Sci. Res.202314135736510.13040/IJPSR.0975‑8232.14(1).357‑65
     [Google Scholar]
  23. PatidarK. BaisN. JainS.K. VengurlekarS. Formulation and evaluation of mucoadhesive microspheres loaded with antidiabetic agents.Int J Adv Res Multidiscip Trends202522397411[IJARMT].10.1016/j.ipha.2024.01.012
     [Google Scholar]
  24. LiB. YangH. ChengK. SongH. ZouJ. LiC. XiaoW. LiuZ. LiaoX. Development of magnetic poly(L-lactic Acid) nanofibrous microspheres for transporting and delivering targeted cells.Colloids Surf. B Biointerfaces202322311317510.1016/j.colsurfb.2023.11317536738703
     [Google Scholar]
  25. BordoloiR. AhmedA.B. BhattacharyaK. Pharmacoscintigraphic evaluation and antidiabetic efficacy of gliclazide-loaded 99mTc-labelled mucoadhesive microspheres.Future J Pharm Sci20217122910.1186/s43094‑021‑00376‑3
     [Google Scholar]
  26. MiaoC. ZhaoM. HamadW.Y. Cellulose nanocrystal/polymer nanocomposite latex via surfactant-free emulsion polymerization.Colloids Surf. A Physicochem. Eng. Asp.202367513192910.1016/j.colsurfa.2023.131929
     [Google Scholar]
  27. HamiltonM. HarringtonS. DharP. Stehno-BittelL. Hyaluronic acid hydrogel microspheres for slow release stem cell delivery.ACS Biomater. Sci. Eng.2021783754376310.1021/acsbiomaterials.1c0065834323078
     [Google Scholar]
  28. CaiH. LiA. QiF. LiuR. TangX. LiD. GuY. LiuJ. Application of biodegradable microsphere injections: An anticancer perspective.Mater Adv2024583094311210.1039/D3MA01150J
     [Google Scholar]
/content/journals/cis/10.2174/012210299X386236251206100034
Loading
Mucoadhesive Gastroretentive Poly (ε-caprolactone) Microspheres for Sustained Release of Acyclovir: Formulation and Characterization
Curr. Indian Sci. 4, e2210299X386236 (2026); https://doi.org/10.2174/012210299X386236251206100034
/content/journals/cis/10.2174/012210299X386236251206100034
/content/journals/cis/10.2174/012210299X386236251206100034
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): Acyclovir; Gastrointestinal tract; Microspheres; Mucoadhesive drug delivery; Solubility; Solvent evaporation

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test